Journal
AMERICAN JOURNAL OF PATHOLOGY
Volume 189, Issue 9, Pages 1732-1743Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2019.05.009
Keywords
-
Categories
Funding
- Alberta Public Laboratories [RS14-518, RS14-520, RS14-527, RS15-500]
Ask authors/readers for more resources
Approximately 15% to 20% of colorectal cancers are developed through the serrated pathway of tumorigenesis, which is associated with BRAF mutation, CpG island methylation phenotype, and MLH1 methylation. However, the detailed process of progression from sessile serrated adenoma (SSA) to dysplasia and carcinoma has not been elucidated. To further characterize mechanisms involved in the dysplastic progression of SSA, we investigated differential expressions of mRNAs between areas with and without dysplasia within the same SSA polyps. Significantly dysregulated genes in paired samples were applied for functional annotation and biological significance. The same lysates from a subset of matched samples were subjected for miRNA expression profiling. Differentially expressed miRNAs were determined, and their targeted mRNAs were compared in parallel to the list of differentially expressed mRNAs from an RNA sequencing study. Fourteen common mRNA targets were identified, which include AXIN2, a known indicator of WNT/beta-catenin pathway activation. Together, in this study, different genes, pathways, and biological processes involved in the initiation and progression of dysplasia in the serrated pathway are documented. One of the most significant findings is the involvement of the WNT/beta-catenin pathway in the dysplastic progression of SSAs with different genes being targeted in early versus advanced dysplasia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available